At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance (PASI 100) and ≥10% weight loss In ...
Indianapolis, Indiana, USA - February 8, 2025: Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Senior Correspondent As more doctors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results